Advertisement
Screener

Nautilus Biotechnology, Inc. (NAUT) Payments to Acquire Businesses, Gross

1.8 / 5 stars · 14/40 Roast Me

Nautilus Biotechnology, Inc. Payments to Acquire Businesses, Gross

Nautilus Biotechnology, Inc. (NAUT) reported Payments to Acquire Businesses, Gross of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireBusinessesGross · last filed 2026-02-26

  • Nautilus Biotechnology, Inc. payments to acquire businesses, gross for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Nautilus Biotechnology, Inc. payments to acquire businesses, gross for fiscal 2024 was $760.00K.
  • Nautilus Biotechnology, Inc. payments to acquire businesses, gross for fiscal 2023 was $0.00.
Period endPayments to Acquire Businesses, Gross 12 month
2025-12-31$0.00
10-K · filed 2026-02-26
2024-12-31$760.00K
10-K · filed 2026-02-26
2023-12-31$0.00
10-K · filed 2025-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quanterix Corp (QTRX)United States$0.150B-1.65
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15